Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis
Recruiting · NCT07042126 · Registry updated 2025-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 3 | 2025-11-18 | NCT07042126 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 18 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine | Nanchang | China | 1 |
| Peking University People's Hospital | Beijing | China | 146 |
| The Fourth Affiliated Hospital Zhejiang University School of Medicine | Jinhua | China | 2 |